期刊文献+

假丝酵母菌药敏检测方法及其耐药性的研究进展 被引量:8

下载PDF
导出
摘要 该文主要介绍了假丝酵母菌的感染现状,耐药机制以及常用的检测方法的最新研究进展,为临床对酵母菌感染的临床用药,减少其耐药性的产生提供相应的参考。
作者 刘灿 王中新
出处 《安徽医药》 CAS 2010年第2期224-226,共3页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献20

  • 1Craun GF, Calderon RL, Wade TJ. Assessing waterborne risks : an introduction [ J ]. J Water Health ,2006,4 (Suppl 2 ) :3 - 18.
  • 2廖致红.念珠菌的耐药研究进展[J].右江医学,2006,34(2):203-206. 被引量:2
  • 3苏丹虹,邬全会,王华成.Rosco真菌药敏试验与其他方法的比较研究[J].检验医学,2004,19(4):291-294. 被引量:19
  • 4Pfaller JB, Messer SA, Hollis R J, et al. In vitro susceptibility testing of Aspergillus spp : comparison of E - test and reference microdilution methods for determining voriconazole and itraconazole MICs [ J ]. J Clin Microbio1,2003,41 ( 3 ) : 1126 - 9.
  • 5Jha S, Karnani N, Lynn AM, et al. Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a candida drug efflux pump [ J ]. Biochem Biophys Res Commun, 2003, 310(3) :869 -75.
  • 6Prasad R, Gaur NA, Gaur M, et ai. Efflux pumps in drug resistance of Candida [ J ]. Infect Disord Drug Targets,2006,6 ( 2 ) :69 - 83.
  • 7Holmes AR, Tsao S, Ong SW, et al. Heterozygosity and functional allelic variation in the candida albicans efflux pump genes CDR1 and CDR2 [ J ]. Mol Microbiol,2006,62 ( 1 ) : 170 - 86.
  • 8Mukherjee PK, Chandra J, Kuhn DM, et al. Mechanism of fluconazole resistance in Candida aibicans biofilms : phase - specific role of efflux pumps and membrane sterols [ J ]. Infect Immun, 2003,71 (8) :4333 -40.
  • 9叶丽娟,王辂,朱辉.抗真菌药物作用机制及真菌耐药机制的研究进展[J].国外医药(抗生素分册),2006,27(5):221-227. 被引量:17
  • 10Smith H, Simons C. Enzyme and their inhibition:drug development [ M]. New York ,CRC press ,2004:66.

二级参考文献55

  • 1范润玉,吴瑶.医院内深部真菌感染166例分析[J].中华医院感染学杂志,1996,6(3):138-140. 被引量:164
  • 2谭文涛 王君.两年间深部真菌菌群分布及耐药分析[J].中华检验医学杂志,2000,23:345-345.
  • 3National Committee for Clinical Latoratory Standards. Minutes US NCCLS antifungal susceptibility Subcommittee meeting on interpretive breakpoints [S]. NCCLS,2002. Villanova, PA.
  • 4黄世杰.FDA专业组推荐caspofungin用于曲霉病[J].国外医学:药学分册,2001,28(3):191-191.
  • 5Andes D, Nett J, Oschel P et al.Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model. Infection and Immunity, 2004,72: 6023
  • 6Ramage G, Saville SP, Wickes BL et al.Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule. Applied and Environmental Microbiology, 2002,68: 5459
  • 7Thurnheer T, Gmur R, Shapiro S et al Mass transport of macromolecules within an in vitro model of supragingival plaque. Appl Environ Microbiol,2003,69:1702
  • 8Al-Fattani MA, Douglas LJ.Penetration of Candida Biofilms by Antifungal Agents. Antimicrobial Agents and Chemotherapy, 2004,48:3291
  • 9Baillie G S, Douglas LJ. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother,1998,42:1900
  • 10Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. Journal of Antimicrobial Chemotherapy,2000, 46: 397

共引文献40

同被引文献37

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部